Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 9
2003 10
2004 2
2005 11
2006 14
2007 9
2008 18
2009 18
2010 26
2011 39
2012 50
2013 48
2014 43
2015 40
2016 61
2017 73
2018 63
2019 47
2020 69
2021 77
2022 83
2023 73
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Results by year

Filters applied: . Clear all
Page 1
Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression.
Lee Y, Chowdhury T, Kim S, Yu HJ, Kim KM, Kang H, Kim MS, Kim JW, Kim YH, Ji SY, Hwang K, Han JH, Hwang J, Yoo SK, Lee KS, Choe G, Won JK, Park SH, Lee YK, Shin JH, Park CK, Kim CY, Kim JI. Lee Y, et al. Among authors: han jh. Exp Mol Med. 2024 Apr;56(4):975-986. doi: 10.1038/s12276-024-01204-3. Epub 2024 Apr 12. Exp Mol Med. 2024. PMID: 38609519 Free PMC article.
Author Correction: Kondo interaction in FeTe and its potential role in the magnetic order.
Kim Y, Kim MS, Kim D, Kim M, Kim M, Cheng CM, Choi J, Jung S, Lu D, Kim JH, Cho S, Song D, Oh D, Yu L, Choi YJ, Kim HD, Han JH, Jo Y, Shim JH, Seo J, Huh S, Kim C. Kim Y, et al. Among authors: han jh. Nat Commun. 2024 Mar 18;15(1):2427. doi: 10.1038/s41467-024-46779-7. Nat Commun. 2024. PMID: 38499568 Free PMC article. No abstract available.
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Kilburn LB, Khuong-Quang DA, Hansford JR, Landi D, van der Lugt J, Leary SES, Driever PH, Bailey S, Perreault S, McCowage G, Waanders AJ, Ziegler DS, Witt O, Baxter PA, Kang HJ, Hassall TE, Han JW, Hargrave D, Franson AT, Yalon Oren M, Toledano H, Larouche V, Kline C, Abdelbaki MS, Jabado N, Gottardo NG, Gerber NU, Whipple NS, Segal D, Chi SN, Oren L, Tan EEK, Mueller S, Cornelio I, McLeod L, Zhao X, Walter A, Da Costa D, Manley P, Blackman SC, Packer RJ, Nysom K. Kilburn LB, et al. Among authors: han jw. Nat Med. 2024 Mar 11. doi: 10.1038/s41591-024-02910-1. Online ahead of print. Nat Med. 2024. PMID: 38467878 No abstract available.
799 results